EFFECTIVENESS OF A TRIPLE NUTRITIONAL INTERVENTION AND PHYSICAL ACTIVITY FOR GLYCOSYLATED HB CONTROL IN PREDIABETICS: CLINICAL TRIAL
The clinical trial sponsored by Bioaraba Health Research Institute aims to evaluate a triple intervention strategy for glycemic control in prediabetic patients, a population at high risk for developing diabetes. Given the increasing prevalence of diabetes globally, this trial addresses a significant market need. The intervention's focus on non-pharmacological approaches may appeal to healthcare systems seeking cost-effective solutions to manage prediabetes. The competitive landscape includes various lifestyle modification programs and pharmacological treatments for diabetes, necessitating a thorough diligence process to assess the trial's potential market positioning and reimbursement pathways.
Indication: Diabetes
Modality: combination therapy
Target: Glycosylated hemoglobin (HbA1c) control through lifestyle modifications including dietary interventions and physical activity.
Sponsor: Bioaraba Health Research Institute
Source URL: ClinicalTrials.gov
Source updated: Feb 11, 2025
Ingested: Jun 19, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Glycosylated hemoglobin (HbA1c) control through lifestyle modifications including dietary interventions and physical activity.
View original source fields
Condition raw: Diabetes
Condition normalized: Diabetes
Modality raw: combination therapy
Modality normalized: combination therapy
Target raw: Glycosylated hemoglobin (HbA1c) control through lifestyle modifications including dietary interventions and physical activity.
Target normalized: Glycosylated hemoglobin (HbA1c) control through lifestyle modifications including dietary interventions and physical activity.